Here’s what you should know.
1. GMI attributes the growth to the rising prevalence of chronic diseases and the success of the ASC model.
2. Analysts believe as more procedures migrate from inpatient to outpatient, reimbursement will follow. However, legislative restrictions could suppress the ASC market.
3. Analysts believe the ophthalmology segment grew the most in 2017, and they’ve said the multispecialty segment has the most growth potential through 2024.
4. The U.S. is the global ASC market leader, but Germany is trailing close behind, where demand is growing for procedures to be done in an outpatient setting.
5. Researchers said, “There has been a significant movement in surgical procedures shifting to hospital outpatient from hospital inpatient, and now to ambulatory surgical centers. This shift is caused due to various reasons, including significant cost savings for payers and patients alike, high-quality outcomes, technology that has allowed more complex procedures to be performed in ASCs and convenience for patients and providers.”
More articles on improving performance:
Allied Pain & Spine opens San Jose-based ASC: 4 key points
14 statistics on orthopedic, pain management net revenue per case at ASCs
4 things to know about Orthopaedic Research and Education Foundation’s new president Dr. Michael Parks
